Oklahoma AG files lawsuit against three opioid distributorsChristian Fernsby ▼ | January 14, 2020
Oklahoma Attorney General Mike Hunter announced he has filed a lawsuit against the McKesson Corporation, Cardinal Health, and AmerisourceBergen Corporation for their alleged role in the ongoing opioid crisis.
Medicine and business Oklahoma Attorney General Mike Hunter
Topics: Oklahoma opioid
Attorney General Hunter said the state is seeking damages for misconduct that fueled diversion, leading to the death of thousands of Oklahomans.
Opioid distributors are required by law to stop and report suspiciously large shipments of opioids to law enforcement officials unless due diligence disproves those suspicions.
The lawsuit claims the companies funneled more opioids into communities across the state than could have been expected to serve a legitimate medical need, while ignoring red flags and suspicious orders. The state alleges negligence and unjust enrichment as a result and is seeking compensatory damages.
All three companies have paid hundreds of millions of dollars in settlements and fines for failing to monitor suspicious orders of opioids.
Since 2008, McKesson has paid over $163 million for its failure to report suspicious orders, including a $150 million settlement with authorities in 2017, which is a record for a distributor.
Since 2008, Cardinal has paid nearly $100 million in multiple actions from authorities and state actions relating to its improper management and distribution of opioids to pharmacies across the United States.
At one point, authorities found that Cardinal’s own investigator warned the company against selling opioids to four pharmacies in Florida that requested a 241% increase of opioids in only two years. Cardinal did not notify authorities or cut off the supply. Instead, Cardinal’s shipment of opioids to the pharmacies increased.
AmerisourceBergen has paid $16 million as a result of prescription opioid diversion. In 2007, the company actually lost its license to send controlled substances from one of its distribution centers due to a lack of control over shipments of prescription opioids. ■